This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "2017-04-13 Patient Care FHIR Call"

From HL7Wiki
Jump to navigation Jump to search
 
(35 intermediate revisions by the same user not shown)
Line 68: Line 68:
 
|colspan="2"| Haas Consulting
 
|colspan="2"| Haas Consulting
 
|-
 
|-
−
| || Rob Hausam
+
| X|| Rob Hausam
 
|colspan="2"| Hausam Consulting LLC
 
|colspan="2"| Hausam Consulting LLC
 
|-
 
|-
Line 74: Line 74:
 
|colspan="2"| Intermountain Healthcare
 
|colspan="2"| Intermountain Healthcare
 
|-
 
|-
−
| || Emma Jones
+
|X || Emma Jones
 
|colspan="2"| Allscripts
 
|colspan="2"| Allscripts
 
|-
 
|-
Line 157: Line 157:
 
#Agenda review
 
#Agenda review
 
#Approve previous meeting minutes [[2017-04-06_Patient_Care_FHIR_Call]]
 
#Approve previous meeting minutes [[2017-04-06_Patient_Care_FHIR_Call]]
−
#*'''Motion:''' <moved>/<seconded>
+
#*'''Motion:''' Stephen/Russ
 
# Transplant Material
 
# Transplant Material
 
# gForge change request
 
# gForge change request
Line 182: Line 182:
 
* [https://chat.fhir.org/#narrow/stream/implementers/subject/Blood.2C.20Tissue.2C.20Organ.3A.20Donation Blood, Tissue, Organ Donation]  
 
* [https://chat.fhir.org/#narrow/stream/implementers/subject/Blood.2C.20Tissue.2C.20Organ.3A.20Donation Blood, Tissue, Organ Donation]  
 
** NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material  
 
** NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material  
−
** It would include things like bone marrow, cord blood, peripheral blood stem cells, solid organs, blood transfusion, etc
+
** It would include things like bone marrow, cord blood, peripheral blood stem cells - and any new resource could also address solid organs and blood transfusion although not part of the initial use case
 
** Align with scope of ISBT128, the purpose of which is:  to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant.  (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
 
** Align with scope of ISBT128, the purpose of which is:  to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant.  (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
 
** Previously, Patient Care had voted to create a new resource, per [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8458 GF#8458]
 
** Previously, Patient Care had voted to create a new resource, per [http://gforge.hl7.org/gf/project/fhir/tracker/?action=TrackerItemEdit&tracker_item_id=8458 GF#8458]
 +
** Transplant material resource would have relationship to two things -- who gave it and who received it
 +
** Also includes examples that might originate from a human, but then manipulated
 +
** Map process/forms to existing resources; profile for transplantation; categorize patients as donor vs recipient/patient
 +
** Specimen is only for diagnostic purposes; Device was considered/debated;
 +
*** Per [http://lists.hl7.org/read/messages?id=288143 OO ListServ], proposed boundaries included
 +
**** '''Device''': a manufactured item that is used in the provision of healthcare without being substantially changed through that activity. The device may be a medical or non-medical device
 +
**** '''Substance''': A homogeneous material with a definite composition
 +
**** '''BiologicallyDerivedProduct''': material extracted from a living mammalian organism or that is still living
 +
** PC recommends creating a logical/domain model - Kirt has started this work via [http://clinfhir.com/logicalModeller.html ClinFHIR] via Model Selector > Graft > Mapping tab
 +
** Desire to have transfusions (blood transfusion) included in scope -- start more broadly with '''BiologicallyDerivedProduct'''
 +
** Motion to support creation of a new "biologically derived product" resource proposal (which will be approved by PC once written):  Eric/Stephen: 10-0-0
  
 +
=== TermInfo Feedback ===
 +
* TermInfo project to be able to reason with data in FHIR and SNOMED - reasoning across both models combined (using OWL) to be able to classify independently of model (pre vs post coordination) - need to understand meaning and possibly update/clarify definitions
 +
* Condition.verificationStatus ([http://build.fhir.org/valueset-condition-ver-status.html condition-ver-status])
 +
** How do we map provisional (= This is a tentative diagnosis - still a candidate that is under consideration) to SNOMED concept model?
 +
*** Probably present (qualifier value)
 +
*** Suspected (qualifier value)
 +
*** Known possible (qualifier value)
 +
** Same question for differential (= One of a set of potential (and typically mutually exclusive) diagnoses asserted to further guide the diagnostic process and preliminary treatment)
 +
* TermInfo will propose mappings for Patient Care to review
 +
* Review current definitions
 +
** '''Provisional''' - The diagnosis that is most likely based on the currently available data.
 +
** '''Differential''' - One of a set of potential (and typically mutually exclusive) diagnoses asserted to further guide the diagnostic process and preliminary treatment.  Potential diagnoses in the list may not have equal probability.
 +
*** Note:  map to "known possible" despite some being more likely than others
 +
** '''Confirmed''' (no change) -- There is sufficient diagnostic and/or clinical evidence to treat this as a confirmed condition.
 +
*** Note: mapping to "known present" -- does this make sense for amputee or no family history of cancer
  
 
=== gForge Change Requests ===
 
=== gForge Change Requests ===
  
 
=== Adjourn ===
 
=== Adjourn ===
−
Adjourned at <hh:mm am/pm> <timezone>.
+
Adjourned at 6:31PM Eastern
  
 
==Meeting Outcomes==
 
==Meeting Outcomes==
Line 207: Line 233:
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 
| width="100%" align="left" style="background:#f0f0f0;"|'''Actions''' ''
 
   
 
   
−
*
+
* Michelle will email Bob, Kirt, and Matt the [http://wiki.hl7.org/index.php?title=Template:FHIR_Resource_Proposal New Resource Proposal Template]
  
 
|-
 
|-

Latest revision as of 23:10, 13 April 2017



Meeting Information

Patient Care FHIR Resources Conference Call

Location: Conference Call
Phone Number: +1 770-657-9270
Participant Passcode: 943377
WebEx: https://cernermeeting.webex.com/join/michelle.m.miller

Date: 2017-04-13
Time: 5-6:30pm ET
Facilitator Michelle M Miller Note taker(s) Michelle M Miller
Attendee Name Affiliation


Elaine Ayres NIH/Department of Clinical Research Informatics
Pushpalatha Bhat
X Stephen Chu The Australian Digital Health Agency (ADHA)
Evelyn Gallego EMI Advisors LLC
X Eric Haas Haas Consulting
X Rob Hausam Hausam Consulting LLC
X Laura Heermann-Langford Intermountain Healthcare
X Emma Jones Allscripts
X Russ Leftwich InterSystems
Tony Little Optum 360
Jay Lyle Ockham Information Services LLC, VA
Russell McDonell Telstra Health
Lloyd McKenzie Gevity (HL7 Canada)
Larry McKnight Cerner
X Michelle M Miller Cerner
Lisa Nelson Life Over Time Solutions
Viet Nguyen Lockheed Martin, Systems Made Simple
M'Lynda Owens Cognosante
Craig Parker Intermountain Healthcare
X Joe Quinn Optum
Simon Sum Academy of Nutrition and Dietetics
Iona Thraen Dept of Veterans Affairs
Serafina Versaggi Dept of Veterans Affairs
X Bob Milius NMDP
X Kirt Schaper CIBMTR
Mike Padula CHOP
X Matt Prestegaard
Quorum Requirements Met: yes

Agenda

Agenda Topics

  1. Agenda review
  2. Approve previous meeting minutes 2017-04-06_Patient_Care_FHIR_Call
    • Motion: Stephen/Russ
  3. Transplant Material
  4. gForge change request

Supporting Information

Minutes

Zulip

  • Blood, Tissue, Organ Donation
    • NMDP (National Marrow Donor Program) and CIBTMR (Center for International Blood and Marrow Transplant Research) would like to participate in helping develop a new resource for transplant material
    • It would include things like bone marrow, cord blood, peripheral blood stem cells - and any new resource could also address solid organs and blood transfusion although not part of the initial use case
    • Align with scope of ISBT128, the purpose of which is: to provide standards and guidance for the coding and labeling of medical products of human origin (MPHO): blood, cellular therapy, tissues, regenerated tissue, milk, fecal microbiota, topical products of human origin, in vivo diagnostic MPHO, and organs for transplant, as well as those plasma derivatives for which ABO is relevant. (we may want to extend the scope to “biological origin” rather than limiting to “human origin”)
    • Previously, Patient Care had voted to create a new resource, per GF#8458
    • Transplant material resource would have relationship to two things -- who gave it and who received it
    • Also includes examples that might originate from a human, but then manipulated
    • Map process/forms to existing resources; profile for transplantation; categorize patients as donor vs recipient/patient
    • Specimen is only for diagnostic purposes; Device was considered/debated;
      • Per OO ListServ, proposed boundaries included
        • Device: a manufactured item that is used in the provision of healthcare without being substantially changed through that activity. The device may be a medical or non-medical device
        • Substance: A homogeneous material with a definite composition
        • BiologicallyDerivedProduct: material extracted from a living mammalian organism or that is still living
    • PC recommends creating a logical/domain model - Kirt has started this work via ClinFHIR via Model Selector > Graft > Mapping tab
    • Desire to have transfusions (blood transfusion) included in scope -- start more broadly with BiologicallyDerivedProduct
    • Motion to support creation of a new "biologically derived product" resource proposal (which will be approved by PC once written): Eric/Stephen: 10-0-0

TermInfo Feedback

  • TermInfo project to be able to reason with data in FHIR and SNOMED - reasoning across both models combined (using OWL) to be able to classify independently of model (pre vs post coordination) - need to understand meaning and possibly update/clarify definitions
  • Condition.verificationStatus (condition-ver-status)
    • How do we map provisional (= This is a tentative diagnosis - still a candidate that is under consideration) to SNOMED concept model?
      • Probably present (qualifier value)
      • Suspected (qualifier value)
      • Known possible (qualifier value)
    • Same question for differential (= One of a set of potential (and typically mutually exclusive) diagnoses asserted to further guide the diagnostic process and preliminary treatment)
  • TermInfo will propose mappings for Patient Care to review
  • Review current definitions
    • Provisional - The diagnosis that is most likely based on the currently available data.
    • Differential - One of a set of potential (and typically mutually exclusive) diagnoses asserted to further guide the diagnostic process and preliminary treatment. Potential diagnoses in the list may not have equal probability.
      • Note: map to "known possible" despite some being more likely than others
    • Confirmed (no change) -- There is sufficient diagnostic and/or clinical evidence to treat this as a confirmed condition.
      • Note: mapping to "known present" -- does this make sense for amputee or no family history of cancer

gForge Change Requests

Adjourn

Adjourned at 6:31PM Eastern

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items
  1. Agenda review
  2. Approve previous meeting minutes
    • Motion: <moved>/<seconded> Abstain - <#>, Negative - <#>, Approve - <#>
  3. gForge change request

© 2012 Health Level Seven® International. All rights reserved.

Retrieved from "https://wiki.hl7.org/w/index.php?title=2017-04-13_Patient_Care_FHIR_Call&oldid=137617"